Aims Bleeding is recognized as one of the most commonly encountered adverse events associated with endoscopic sphincterotomy (EST). Although various techniques for endoscopic hemostasis have been reported, the treatment choice is left to the endoscopist. A novel self-assembling and fully synthetic hydrogel peptide (hemostatic gel) is currently developed as a hemostatic agent. This study aimed to evaluate the feasibility and effectiveness of the application of hemostatic gel to EST-related hemorrhage.
No takes yet. Share an insight, caveat, or question.
Ishida et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: